In a report of one myoclonus dystonia patient with double mutations in the DYT-TOR1 A and DYT11 genes, bilateral VIM DBS resulted in a BFMDRS motor score decreasing from 35 to 8, the BFMDRS disability score decreasing from 17 to 5, and the Unified Myoclonus Rating Scale rest/action sub_score decreasing from 24 to 0 after six months of therapy [42]. Here, SGCE is linked to myoclonus-dystonia syndrome.